Early morbidity and mortality after one-stage bilateral shoulder arthroplasty.

Abstract

One-stage bilateral shoulder arthroplasty has the advantage of requiring a single hospital stay and a single anaesthesia. The topic has been little reported, unlike onestage bilateral hip and knee arthroplasty, which have demonstrated their interest. The aim of the present study was to determine peri- and early post-operative morbidity and mortality after this procedure. The study hypothesis was that peri- and early post-operative morbidity and mortality in onestage bilateral shoulder arthroplasty is low in selected patients and that satisfaction is high. A single-centre retrospective study assessed peri- and early post-operative morbidity and mortality in onestage bilateral shoulder arthroplasty. Twenty-one patients, aged < 80years, with ASA score ≤ 3, were consecutively operated on between 1999 and 2020. Indications comprised primary osteoarthritis, aseptic osteonecrosis, inflammatory arthritis, massive rotator cuff tear, and dislocation fracture, involving both shoulders. There were no early deaths. The complication rate was 10% (4/21 cases). No prosthesis dislocation or sepsis was reported. Mean blood loss was 145 ± 40cc, mean surgery time 164 ± 63min, and mean hospital stay five ± fourdays. Only one patient required postoperative transfusion. Functional results at sixmonths showed significantly improved range of motion and good patient satisfaction. One-stage bilateral shoulder arthroplasty was feasible in selected patients. Mortality was zero, and morbidity was low. Surgery time was reasonable and required no repositioning. Postoperative home help is indispensable for patient satisfaction during rehabilitation.